drugset / Trial / NCT02385760
CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris
Phase 2
Completed
124 enrolled
Celtaxsys, Inc.
Celtaxsys Aus Pty Limited · collabClinical Network Services (CNS) Pty Ltd · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
A multi-centre, double-blind, randomized, parallel group, placebo controlled efficacy and safety study of oral CTX-4430 for the treatment of moderate to severe facial acne vulgaris.
Timeline
- Start
- 2015-04
- Primary completion
- 2016-05
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acebilustat | Small molecule | 100 mg | Oral |